Myriad Genetics Statistics
Total Valuation
MYGN has a market cap or net worth of $1.13 billion. The enterprise value is $1.17 billion.
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MYGN has 91.04 million shares outstanding. The number of shares has increased by 9.79% in one year.
| Current Share Class | 91.04M |
| Shares Outstanding | 91.04M |
| Shares Change (YoY) | +9.79% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 2.05% |
| Owned by Institutions (%) | 94.54% |
| Float | 83.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 177.86 |
| PS Ratio | 1.35 |
| Forward PS | 1.27 |
| PB Ratio | 1.54 |
| P/TBV Ratio | 8.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 65.56 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.90 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.80 |
Financial Efficiency
Return on equity (ROE) is -16.39% and return on invested capital (ROIC) is -6.78%.
| Return on Equity (ROE) | -16.39% |
| Return on Assets (ROA) | -5.35% |
| Return on Capital (ROIC) | -6.78% |
| Revenue Per Employee | $305,037 |
| Profits Per Employee | -$42,963 |
| Employee Count | 2,700 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 9.91 |
Taxes
| Income Tax | -700,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.77% in the last 52 weeks. The beta is 1.89, so MYGN's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | -39.77% |
| 50-Day Moving Average | 14.92 |
| 200-Day Moving Average | 22.03 |
| Relative Strength Index (RSI) | 29.80 |
| Average Volume (20 Days) | 1,030,003 |
Short Selling Information
The latest short interest is 4.78 million, so 5.25% of the outstanding shares have been sold short.
| Short Interest | 4.78M |
| Short Previous Month | 3.35M |
| Short % of Shares Out | 5.25% |
| Short % of Float | 5.70% |
| Short Ratio (days to cover) | 4.47 |
Income Statement
In the last 12 months, MYGN had revenue of $823.60 million and -$116.00 million in losses. Loss per share was -$1.30.
| Revenue | 823.60M |
| Gross Profit | 569.50M |
| Operating Income | -95.40M |
| Pretax Income | -156.60M |
| Net Income | -116.00M |
| EBITDA | -33.90M |
| EBIT | -95.40M |
| Loss Per Share | -$1.30 |
Full Income StatementBalance Sheet
The company has $99.90 million in cash and $143.10 million in debt, giving a net cash position of -$43.20 million or -$0.47 per share.
| Cash & Cash Equivalents | 99.90M |
| Total Debt | 143.10M |
| Net Cash | -43.20M |
| Net Cash Per Share | -$0.47 |
| Equity (Book Value) | 731.70M |
| Book Value Per Share | 8.04 |
| Working Capital | 138.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.00 million and capital expenditures -$25.40 million, giving a free cash flow of -$95.40 million.
| Operating Cash Flow | -70.00M |
| Capital Expenditures | -25.40M |
| Free Cash Flow | -95.40M |
| FCF Per Share | -$1.05 |
Full Cash Flow StatementMargins
Gross margin is 69.15%, with operating and profit margins of -11.58% and -14.08%.
| Gross Margin | 69.15% |
| Operating Margin | -11.58% |
| Pretax Margin | -14.17% |
| Profit Margin | -14.08% |
| EBITDA Margin | -4.12% |
| EBIT Margin | -11.58% |
| FCF Margin | n/a |
Dividends & Yields
MYGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.79% |
| Shareholder Yield | -9.79% |
| Earnings Yield | -10.28% |
| FCF Yield | -8.46% |
Dividend DetailsAnalyst Forecast
The average price target for MYGN is $23.92, which is 93.06% higher than the current price. The consensus rating is "Hold".
| Price Target | $23.92 |
| Price Target Difference | 93.06% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 8.64% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 26, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Mar 26, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MYGN has an Altman Z-Score of 3.07 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.07 |
| Piotroski F-Score | 4 |